Eli Lilly CEO Sidney Taurel said the company does not plan any major changes to the size of its sales force, even as rivals cut jobs.
“We won’t grow our sales force,” Taurel told cable network CNBC. “There has been some reduction…of our sales force. But we don’t see major decreases.”
Taurel said Lilly has already decreased its total work force by 4,500, or 10%, since the middle of 2004.
Late last year, Pfizer announced cuts to its US and European sales forces by at least 20%.
And AstraZeneca said earlier this month it plans to cut 3,000 jobs, or 4.6% of its workforce.